National Comprehensive Cancer Network



About NCCN

Non-Hodgkin`s Lymphomas Panel - Disclosures as of 6/14/2012

View NCCN Management Team Disclosures | View NCCN Guidelines Staff Disclosures | View NCCN ORP Staff Disclosures

Panel Member Clinical Research Support/Data Safety Monitoring Board Scientific Advisory Boards, Consultant, or Expert Witness Promotional Advisory Boards, Consultant, or Speakers Bureau Employment/ Governing Board, Patent, Equity, or Royalty Spouse/Domestic Partner/Dependent Potential Conflict Attendance

Jeremy S. Abramson, MD

None

Seattle Genetics, Inc.

None

None

None

Ranjana H. Advani, MD

None

Celgene Corporation;
Sanofi Oncology;
Seattle Genetics

None

None

None

C. Babis Andreadis, MD, MSCE

None

Allos

None

None

Roche Laboratories, Inc.

Nancy Bartlett, MD

None

Seattle Genetics

None

None

None

Naresh Bellam, MD, MPH

None

None

None

None

None

R. Gregory Bociek, MD, MSc

None

Seattle Genetics

None

None

None

John C. Byrd, MD

None

None

None

None

None

Myron S. Czuczman, MD

None

Celgene Corporation;
Genentech, Inc.;
Millennium Pharmaceuticals, Inc.;
Onyx Pharmaceuticals, Inc.

None

None

None

Mary Dwyer, MS

None

None

None

None

None

Luis E. Fayad, MD

Centocor, Inc.;
Eisai Inc.;
Eli Lilly and Company;
Genentech, Inc.;
GlaxoSmithKline;
Novartis Pharmaceuticals Corporation;
Pfizer Inc.;
Roche Laboratories, Inc.;
Roche Laboratories, Inc.;
sanofi-aventis U.S.;
Wyeth Pharmaceuticals

None

None

None

None

Lauren Gallagher, RPh, PhD

None

None

None

None

None

Martha J. Glenn, MD

None

None

None

None

None

Jon P. Gockerman, MD

None

None

None

None

None

Leo I. Gordon, MD

None

CureTech Ltd.

None

CureTech Ltd.

None

Kristina M. Gregory, RN, MSN, OCN

None

None

None

None

None

Nancy Lee Harris, MD

None

None

None

None

None

Richard T. Hoppe, MD

None

None

None

None

None

Steven M. Horwitz, MD

None

Bristol-Myers Squibb Company;
Celgene Corporation;
Genzyme Corporation;
Merck & Co., Inc.;
Allos;
Kiowa-Kirin;
Seattle Genetics

None

None

None

Christopher R. Kelsey, MD

None

None

None

None

None

Youn H. Kim, MD

None

Celgene Corporation;
Merck & Co., Inc.;
Millennium Pharmaceuticals, Inc.;
Allos therapeutics;
Kyowa

None

None

None

Susan Krivacic, MPAff

None

None

None

None

None

Ann S. LaCasce, MD

None

None

None

None

None

Joan S. McClure, MS

None

None

None

None

None

Auayporn Nademanee, MD

None

None

None

None

None

Elise A. Olsen, MD

None

Merck & Co., Inc.

None

None

None

Pierluigi Porcu, MD

None

Therakos, Inc.

None

None

None

Oliver Press, MD, PhD

Genentech, Inc.;
Roche Laboratories, Inc.

Genentech, Inc.;
Millennium Pharmaceuticals, Inc.;
Onyx Pharmaceuticals, Inc.;
Algeta;
Allos;
FujiFilm;
Seattle Genetics;
Roche Laboratories, Inc.

None

Emergent Biosolutions

None

Barbara Pro, MD

None

Celgene Corporation;
allos

None

None

None

Nishitha Reddy, MD

None

None

None

None

None

Lubomir Sokol, MD, PhD

None

Alexion Pharmaceuticals, Inc.;
Celgene Corporation;
Celgene Corporation;
Eisai Inc.;
MedImmune Inc.;
Allos

None

None

None

Lode J. Swinnen, MB, ChB

Abbott Laboratories

None

None

None

None

Christina Tsien, MD

None

None

None

None

None

Julie M. Vose, MD, MBA

None

None

None

None

None

William G. Wierda, MD, PhD

Abbott Laboratories;
GlaxoSmithKline

Celgene Corporation;
Genentech, Inc.;
Roche Laboratories, Inc.

None

None

None

Joachim Yahalom, MD

None

None

None

None

None

Nadeem Zafar, MD

None

None

None

None

None

Andrew D. Zelenetz, MD, PhD

None

Abbott Laboratories;
Celgene Corporation;
Cell Therapeutics, Inc.;
Cephalon, Inc.;
Genentech, Inc.;
GlaxoSmithKline;
Allos;
Cancer Genetics;
Gilead;
Seattle Genetics;
Roche Laboratories, Inc.;
sanofi-aventis U.S.

None

None

None